(Q36190545)

12 August 2017

1 reference

title

Buprenorphine in cancer pain (English)

1 reference

12 August 2017

Mellar P Davis

1

1 reference

12 August 2017

publication date

12 July 2005

1 reference

Supportive Care in Cancer

12 August 2017

published in

1 reference

12 August 2017

volume

13

1 reference

12 August 2017

issue

11

1 reference

12 August 2017

page(s)

878-887

1 reference

A trial of sublingual buprenorphine in cancer pain

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-005-0849-9

A comparative study of intramuscular buprenorphine and morphine in the treatment of chronic pain of malignant origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-005-0849-9

Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-005-0849-9

Delta opioid antagonist effects of buprenorphine in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-005-0849-9

Systemic uptake of buprenorphine by cats after oral mucosal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-005-0849-9

A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry(HILIC-MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-005-0849-9

Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naı̈ve healthy male volunteers under a naltrexone block

21 January 2018

1 reference

12 December 2020

Sublingual buprenorphine tablets: initial clinical experiences in long-term therapy of cancer pain

1 reference

12 December 2020

Relative bioavailability of different buprenorphine formulations under chronic dosing conditions

1 reference

12 December 2020

[Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients]

1 reference

12 December 2020

Methadone--metabolism, pharmacokinetics and interactions

1 reference

12 December 2020

Buprenorphine prevents and reverses the expression of chronic etorphine-induced sensitization of adenylyl cyclase in SK-N-SH human neuroblastoma cells.

1 reference

12 December 2020

Practice guidelines for transdermal opioids in malignant pain

1 reference

12 December 2020

Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin

1 reference

12 December 2020

Buprenorphine TDS: the clinical development rationale and results.

1 reference

12 December 2020

Acute respiratory effects of sublingual buprenorphine: comparison with intramuscular morphine

1 reference

12 December 2020

Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence

1 reference

12 December 2020

Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro

1 reference

12 December 2020

[Long-term therapy of cancer pain. A controlled study on buprenorphine]

1 reference

12 December 2020

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

1 reference

12 December 2020

A new series of 13 buprenorphine-related deaths

1 reference

12 December 2020

Fatal intoxication following self-administration of a massive dose of buprenorphine

1 reference

12 December 2020

Buprenorphine and the transdermal system: the ideal match in pain management.

1 reference

12 December 2020

Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality

1 reference

12 December 2020

[Buprenorphine in cancer pain: cross comparison with pentazocine]

1 reference

12 December 2020

Buprenorphine has potent kappa opioid receptor antagonist activity

1 reference

12 December 2020

Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study

1 reference

12 December 2020

Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice

1 reference

12 December 2020

A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin

1 reference

12 December 2020

The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268).

1 reference

12 December 2020

Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

1 reference

12 December 2020

Buprenorphine vs. morphine via the epidural route: a controlled comparative clinical study of respiratory effects and analgesic activity

1 reference

12 December 2020

Effect of nonspecific binding to microsomes and metabolic elimination of buprenorphine on the inhibition of cytochrome P4502D6.

1 reference

12 December 2020

Epidural buprenorphine or morphine for the relief of head and neck cancer pain

1 reference

12 December 2020

Buprenorphine TDS: use in daily practice, benefits for patients.

1 reference

12 December 2020

Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3

1 reference

12 December 2020

"Patient demand" postoperative analgesia with buprenorphine. Comparison between sublingual and i.m. administration

1 reference

12 December 2020

Palliative care in a national cancer center: results in 1987 vs. 1993 vs. 2000.

1 reference

12 December 2020

The metabolism and excretion of buprenorphine in humans

1 reference

12 December 2020

Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats

1 reference

12 December 2020

Intranasal bioavailability of buprenorphine in rabbit correlated to sheep and man.

1 reference

12 December 2020

Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain

1 reference

12 December 2020

Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives

1 reference

12 December 2020

Tramadol-benzodiazepines and buprenorphine-benzodiazepines: two potentially fatal cocktails?

1 reference

12 December 2020

The incidence of narcotic-induced emesis

1 reference

12 December 2020

Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine

1 reference

12 December 2020

[Effect of a long-acting analgesic, buprenorphine on cancer pain--a single-blind crossover comparison with pentazocine]

1 reference

12 December 2020

Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases

1 reference

12 December 2020

Buprenorphine: considerations for pain management

1 reference

12 December 2020

Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain

1 reference

12 December 2020

Buprenorphine: new pharmacological aspects.

1 reference

12 December 2020

Continuous subcutaneous infusion of buprenorphine for cancer pain control.

1 reference

12 December 2020

Epidural buprenorphine versus morphine in bone cancer pain

1 reference

12 December 2020

Transdermal buprenorphine

1 reference

12 December 2020

A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazocine in cancer pain

1 reference

12 December 2020

Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets

1 reference

12 December 2020

Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia

1 reference

12 December 2020

Buprenorphine: a primer for emergency physicians

1 reference

12 December 2020

Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome

1 reference

12 December 2020

Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling

1 reference

12 December 2020

Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocine

1 reference

12 December 2020

Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats

1 reference

12 December 2020

In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.

1 reference

12 December 2020

A clinical note on sublingual buprenorphine

1 reference

12 December 2020

Use of buprenorphine after right hepatectomy

1 reference

12 December 2020

Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial.

1 reference

12 December 2020

The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases

1 reference

12 December 2020

Kappa antagonist properties of buprenorphine in the shock titration procedure

1 reference

12 December 2020

Bupreorphine:a new pharmacotherapy for opioid addictions treatment

1 reference

12 December 2020

Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice

1 reference

12 December 2020

Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice

1 reference

12 December 2020

Crossover trials in clinical analgesic assays: studies of buprenorphine and morphine

1 reference

12 December 2020

Transdermal delivery of buprenorphine through cadaver skin.

1 reference

12 December 2020

Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.

1 reference

12 December 2020

Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone

1 reference

12 December 2020

A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths

1 reference

12 December 2020

Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet

1 reference

12 December 2020

Subarachnoid buprenorphine administered by implantable micropumps

1 reference

12 December 2020

Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation

1 reference

12 December 2020

Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations

1 reference

12 December 2020

Effect of buprenorphine on CYP3A activity in rat and human liver microsomes

1 reference

12 December 2020

Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence

1 reference

12 December 2020

The orvinols and related opioids--high affinity ligands with diverse efficacy profiles

1 reference

12 December 2020

Intra-muscular buprenorphine--clinical experience in its use for relieving pain due to malignant disease

1 reference

12 December 2020

Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4.

1 reference

12 December 2020

The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid rece

1 reference

12 December 2020

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine

1 reference

12 December 2020

Inhibition of human drug metabolizing cytochrome P450 by buprenorphine

1 reference

12 December 2020

10.1007/S00520-005-0849-9

Identifiers

DOI

1 reference

12 August 2017

1 reference